Logo image of CERO

CERO THERAPEUTICS HOLDINGS I (CERO) Stock Analyst Earnings Estimates

NASDAQ:CERO - Nasdaq - US71902K1051 - Common Stock - Currency: USD

1.79  -0.26 (-12.68%)

After market: 1.71 -0.08 (-4.47%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
CERO revenue by date.CERO revenue by date.
EBITDA
YoY % growth
CERO ebitda by date.CERO ebitda by date.
N/AN/AN/A
EBIT
YoY % growth
CERO ebit by date.CERO ebit by date.
-332K-2.905M
-775.12%		-2.933M
-0.95%
Operating Margin
CERO operating margin by date.CERO operating margin by date.
N/AN/AN/A
EPS
YoY % growth
CERO eps by date.CERO eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
CERO Yearly EPS VS EstimatesCERO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
CERO Yearly Revenue VS EstimatesCERO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A